Vault-13

M28 Capital Management LP

STAMFORD, CT · CIK 1807489 · 13F filing filed 2026-08-13

Exempt reporting adviser since 2026 · limited partnership

As an employer

$47.2m reported value -12.3% vs Q1 2026
9positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,588,284 $26.7m56.53% 56.53% UnchangedShares held: Q3 2025 5.7m, Q4 2025 5.7m, Q1 2026 4.6m, Q2 2026 4.6m
2 INVIVYD INC COM IVVD IVVD 9,248,250 $8.1m17.11% 17.11% UnchangedShares held: Q3 2025 9.2m, Q4 2025 9.2m, Q1 2026 9.2m, Q2 2026 9.2m
3 TG THERAPEUTICS INC COM TGTX TGTX 88,354 $4.9m10.29% 10.29% UnchangedShares held: Q3 2025 161.6k, Q4 2025 161.6k, Q1 2026 88.4k, Q2 2026 88.4k
4 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 36,851 $3.0m6.37% 6.37% UnchangedShares held: Q3 2025 67.4k, Q4 2025 67.4k, Q1 2026 36.9k, Q2 2026 36.9k
5 FRACTYL HEALTH INC COM COM 1,856,117 $1.5m3.13% 3.13% UnchangedShares held: Q3 2025 1.9m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
6 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 599,793 $1.1m2.37% 2.37% UnchangedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 599.8k, Q2 2026 599.8k
7 SILENCE THERAPEUTICS PLC ADS SLN SLN 101,203 $1.1m2.36% 2.36% UnchangedShares held: Q3 2025 185.1k, Q4 2025 185.1k, Q1 2026 101.2k, Q2 2026 101.2k
8 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 210,871 $721.2k1.53% 1.53% UnchangedShares held: Q3 2025 385.7k, Q4 2025 385.7k, Q1 2026 210.9k, Q2 2026 210.9k
9 CURIS INC COM COM 284,889 $148.7k0.32% 0.32% UnchangedShares held: Q3 2025 521.1k, Q4 2025 521.1k, Q1 2026 284.9k, Q2 2026 284.9k